Buyouts have long been a staple feature of the med-tech landscape. While giants like Johnson & Johnson (JNJ), Medtronic (MDT), and Abbott Labs (ABT)
are often knocked (and often unfairly) for their inability to innovate,
they do excel at marketing. That creates a pretty steady conveyor belt
where smaller, innovative companies create new devices that move the
state of the art forward and large companies gobble them up to goose
their own growth and leverage their existing production and sales
infrastructures.
Please read more here:
Med-Tech Due For More M&A
No comments:
Post a Comment